💥 Dragon Pharma

DIHEXA

✔️ Substance: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
✔️ Price For: Vial 10 mg
✔️ Brand: Dragon Pharma

Out of stock

Dragon Pharma DIHEXA

IDENTITYCompound DIHEXA (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)
BrandDragon Pharma
Strength10 mg
FormLyophilized Vial
Class Research Peptide / Cognitive Compound

PEPTIDE PROFILEStructureSmall synthetic peptide derivative
Origin Derived from angiotensin IV analogue research
Primary TargetHGF/c-Met signaling pathway
Research AreaNeuroplasticity & Cognitive Function
StatusExperimental Compound

PHARMACOLOGYMechanism Modulation of HGF/c-Met pathway
Neural ActivitySynaptic Plasticity Research
Administration Subcutaneous (SC) Research Use
MetabolismPeptide Degradation Pathways
Clinical StatusNot FDA Approved Medication

STORAGE & PACKAGEBrandDragon Pharma
Package10 mg Multi-dose Vial
Storage2-8°C Before Reconstitution
After MixingRefrigerated Storage Recommended
Protect FromLight & Heat

ADMINISTRATION PROFILERouteSubcutaneous Injection (SC)
PreparationReconstitution Required
UsageExperimental Cognitive Research
Timing Daily Administration Research Models
Cycle Length Research Periods 4-12 Weeks

DOSING INFORMATIONResearch DoseNot Established Clinically
Common Research Range0.5-2 mg/day
Weekly Exposure3.5-14 mg/week
Administration FrequencyDaily Research Protocols
Duration4-12 Weeks Research Period

USAGE PROFILEMain ResearchCognitive Function
Brain ActivityNeuroplasticity Research
MemoryLearning Pathway Studies
RecoveryNeural Recovery Research
Bodybuilding Indirect Cognitive Support Interest

BODYBUILDING USAGECategory Non-Anabolic Research Compound
Muscle GrowthNo Direct Anabolic Activity
Training SupportCognitive Focus Research
Recovery Potential Neural Recovery Interest
PCTNot Required

SAFETY PROFILEHormonal SuppressionNot Reported
Liver ToxicityNo Established Data
Cardiovascular RiskInsufficient Clinical Data
Long Term SafetyUnknown
Medical StatusResearch Compound

CONTRAINDICATIONSPregnancyNot Recommended
BreastfeedingAvoid
Medical ConditionsProfessional Evaluation Required
Drug InteractionLimited Data
Research StatusExperimental Use Only

MECHANISM OF ACTIONPrimary TargetHepatocyte Growth Factor (HGF) / c-Met Pathway
Neural EffectResearch on Synaptic Plasticity
Brain SignalingNeurotrophic Pathway Modulation
MemoryCognitive Function Research
Cellular ActionGrowth Factor Signaling Research

PHARMACOKINETICSAbsorption Dependent on Administration Route
Half-LifeNot Fully Established
DistributionPeptide Tissue Interaction
MetabolismProteolytic Breakdown
ClearanceLimited Human Data Available

RECONSTITUTION & HANDLINGPreparationSterile Reconstitution Required
Diluent Bacteriostatic Water Research Standard
Storage After MixingRefrigerated Conditions
HandlingAvoid Heat & Direct Light
Stability Peptide Stability Dependent on Conditions

RECOVERY PCTNot Applicable
Hormonal RecoveryNo Known HPTA Suppression
Stopping TimeNo Established Withdrawal Protocol
Monitoring Research Observation Recommended
DurationBased on Research Design

COMPATIBILITYCognitive ResearchNootropic Research Compounds
Peptide ResearchCompatible Research Category
Anabolic CyclesNo Direct Anabolic Interaction Data
Recovery ProgramsPotential Research Interest
SupportNutrition & Training Fundamentals

PERFORMANCE PROFILE

Muscle Gain

10%

Strength

15%

Cognitive Focus

75%

Recovery Support

55%

Hormonal Impact

POTENTIAL BENEFITS

Research interest in cognitive pathways
Potential support of synaptic plasticity studies
Neurotrophic signaling investigation
Non-hormonal compound profile
No known anabolic suppression mechanism
Interest in focus and mental performance research

POTENTIAL RISKS

Limited human clinical data
Long-term effects remain unknown
Experimental compound status
Possible unknown peptide-related reactions
Insufficient interaction studies
No established medical dosing guidelines

WHAT IS DRAGON PHARMA?

Dragon Pharma is a pharmaceutical research brand recognized within the bodybuilding and performance-enhancement community for producing a range of research compounds, peptides, and sports-related pharmaceutical products.

The brand focuses on laboratory-oriented formulations with attention to compound identity, concentration accuracy, sterile production standards, and product consistency. Dragon Pharma products are commonly discussed among athletes and researchers interested in advanced pharmacology topics.

Product quality, authenticity verification, proper storage conditions, and responsible handling are important considerations when evaluating any research compound.

WHY CHOOSE DRAGON PHARMA

Dragon Pharma DIHEXA 10 mg is selected by research-focused users because of its clearly identified peptide composition, standardized vial format, and pharmaceutical-style presentation.

Important factors associated with choosing a research compound include transparent labeling, accurate concentration information, proper packaging, and appropriate storage requirements.

Dragon Pharma products are commonly referenced by bodybuilding communities researching advanced compounds beyond traditional anabolic agents.

OVERVIEW

Dragon Pharma DIHEXA 10 mg contains DIHEXA (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide), an experimental peptide compound investigated for its potential effects on neuroplasticity, cognitive signaling and growth factor pathways.

Unlike anabolic steroids, testosterone derivatives or growth hormone products, DIHEXA does not function through androgen receptors and does not directly stimulate muscle protein synthesis. Its interest among bodybuilding communities is mainly connected to possible cognitive performance, training focus and neural recovery research.

Scientific investigations have focused primarily on the interaction between DIHEXA and the HGF/c-Met signaling system, a pathway associated with cellular communication and neural development research.

CONCLUSION

Dragon Pharma DIHEXA 10 mg contains DIHEXA, an experimental peptide compound researched for possible effects involving neuroplasticity and HGF/c-Met signaling pathways.

Unlike anabolic steroids, DIHEXA does not provide direct androgenic muscle-building effects, does not require PCT, and is not associated with traditional testosterone suppression mechanisms. Its primary research interest is related to cognitive and neurological pathways rather than direct physique enhancement.

Current scientific information remains limited, and DIHEXA should be considered an experimental research compound. Proper evaluation of available evidence, product authenticity, and responsible handling practices are essential when discussing any investigational substance.

DISCLAIMER

This content is provided exclusively for educational and informational purposes. DIHEXA is an experimental compound and is not approved as a prescription medicine for bodybuilding, cognitive enhancement, or performance improvement. This information does not constitute medical advice, treatment recommendations, or endorsement of non-medical use.

Readers should consult qualified healthcare professionals regarding medical questions, safety considerations, and applicable regulations in their jurisdiction.